Unaudited Condensed Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Total	Series A Preferred Stock	Preferred Stock Series A Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income	Accumulated Deficit
Beginning balance, preferred stock, shares outstanding (in shares) at Dec. 31, 2021			0
Beginning balance at Dec. 31, 2021	$ 478,047		$ 0	$ 42	$ 585,397	$ (282)	$ (107,110)
Beginning balance, common stock, shares outstanding (in shares) at Dec. 31, 2021				41,817,503
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Fees incurred for registration filings	(130)				(130)
Stock-based compensation	17,671				17,671
Stock option exercises (in shares)				158,075
Stock option exercises	307				307
Stock issued - on vested RSAs (in shares)				666,336
Stock issued – on vested RSAs	0			$ 1	(1)
Contingent consideration shares issued (in shares)				64,130
Contingent consideration shares issued	816				816
Foreign currency translation	(900)					(900)
Unrealized gain (loss) on available-for-sale securities	(75)					(75)
Net loss	(90,616)						(90,616)
Ending balance, preferred stock, shares outstanding (in shares) at Sep. 30, 2022			0
Ending balance at Sep. 30, 2022	405,120		$ 0	$ 43	604,060	(1,257)	(197,726)
Ending balance, common stock, shares outstanding (in shares) at Sep. 30, 2022				42,706,044
Beginning balance, preferred stock, shares outstanding (in shares) at Jun. 30, 2022			0
Beginning balance at Jun. 30, 2022	409,544		$ 0	$ 43	597,810	(900)	(187,409)
Beginning balance, common stock, shares outstanding (in shares) at Jun. 30, 2022				42,536,734
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Fees incurred for registration filings	(55)				(55)
Stock-based compensation	6,299				6,299
Stock option exercises (in shares)				3,571
Stock option exercises	6				6
Stock issued - on vested RSAs (in shares)				165,739
Foreign currency translation	(321)					(321)
Unrealized gain (loss) on available-for-sale securities	(36)					(36)
Net loss	(10,317)						(10,317)
Ending balance, preferred stock, shares outstanding (in shares) at Sep. 30, 2022			0
Ending balance at Sep. 30, 2022	405,120		$ 0	$ 43	604,060	(1,257)	(197,726)
Ending balance, common stock, shares outstanding (in shares) at Sep. 30, 2022				42,706,044
Beginning balance, preferred stock, shares outstanding (in shares) at Dec. 31, 2022		0	0
Beginning balance at Dec. 31, 2022	$ 364,188		$ 0	$ 43	611,739	(679)	(246,915)
Beginning balance, common stock, shares outstanding (in shares) at Dec. 31, 2022	42,832,231			42,832,231
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	$ 23,337				23,337
Stock option exercises (in shares)				175,043
Stock option exercises	369				369
Stock issued - on vested RSAs (in shares)				923,128
Stock issued – on vested RSAs	1			$ 1
Contingent consideration shares issued (in shares)				116,973
Contingent consideration shares issued	2,263				2,263
Settlement of Global Cooling escrow (in shares)				(216,024)
Settlement of Global Cooling escrow	(5,115)				(5,115)
Foreign currency translation	(25)					(25)
Unrealized gain (loss) on available-for-sale securities	44					44
Net loss	(53,045)						(53,045)
Ending balance, preferred stock, shares outstanding (in shares) at Sep. 30, 2023		0	0
Ending balance at Sep. 30, 2023	$ 332,017		$ 0	$ 44	632,593	(660)	(299,960)
Ending balance, common stock, shares outstanding (in shares) at Sep. 30, 2023	43,831,351			43,831,351
Beginning balance, preferred stock, shares outstanding (in shares) at Jun. 30, 2023			0
Beginning balance at Jun. 30, 2023	$ 352,128		$ 0	$ 43	623,412	(499)	(270,828)
Beginning balance, common stock, shares outstanding (in shares) at Jun. 30, 2023				43,442,250
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	9,117				9,117
Stock option exercises (in shares)				31,000
Stock option exercises	64				64
Stock issued - on vested RSAs (in shares)				358,101
Stock issued – on vested RSAs	1			$ 1
Foreign currency translation	(165)					(165)
Unrealized gain (loss) on available-for-sale securities	4					4
Net loss	(29,132)						(29,132)
Ending balance, preferred stock, shares outstanding (in shares) at Sep. 30, 2023		0	0
Ending balance at Sep. 30, 2023	$ 332,017		$ 0	$ 44	$ 632,593	$ (660)	$ (299,960)
Ending balance, common stock, shares outstanding (in shares) at Sep. 30, 2023	43,831,351			43,831,351